March 20th, 2003 — TissueInformatics.Inc — "The Tissue Information Company®".
Pittsburgh —

TissueInformatics (www.TissueInformatics.com) announced today that its Chairman and CEO, Dr. Peter Johnson MD, has been appointed Co-Editor-in-Chief of the prestigious Journal Tissue Engineering (www.liebertpub.com/ten) The Journal is published by Mary Ann Liebert, Inc., the publisher of Genetic Engineering News, the most widely read publication in the biotechnology field.

Tissue Engineering is a peer-review journal that provides a forum of papers, reports and reviews of scientific research and advances in engineering new functional tissue. The interdisciplinary field of Tissue Engineering applies the principles and methods of engineering and the life sciences towards the functional understanding of structure-function relationships in normal and pathologic tissue and development of biological substitutes.

"We are delighted that Dr. Johnson will be assuming the role of Co-Editor-in-Chief. He has enormous energy and innovative ideas that will help move the Journal into the future," said Mary Ann Liebert, President and CEO of Mary Ann Liebert, Inc., publishers.

Dr. Johnson will leverage his background as reconstructive surgeon, cell biologist and Founder of the Pittsburgh Tissue Engineering Initiative with his business skills to focus on strategic impact issues for the Journal. These include structuring of the direction of the Journal as well as guidance of editorial policy, critical reviews and best practices of the Editorial Board in order to continue to enhance the Journal's impact.

"Dr. Johnson is a pioneer of the tissue engineering field. He has provided exceptional leadership and will help further enhance the impact of the Journal." said Dr. Antonios Mikos. Dr. Mikos will continue as Co-Editor-in-Chief and will oversee the now centralized Editorial Office at Rice University where he will guide manuscript recruitment, assignment and review with Dr. Johnson's assistance.

Dr. Johnson is also Co-Founder, Chairman and CEO of TissueInformatics. TissueInformatics accelerates the drug discovery process by providing a broad range of tissue analysis services, tissue analysis software and drug discovery partnering solutions to the pharmaceutical, biotechnology and CRO industries. TissueInformatics' industry-wide expertise in tissue image capture and analysis, thorough scientific understanding of tissue morphology and extensive experience in performing daily slide analysis in its own TissueAnalytics™ Laboratory, allows TissueInformatics to provide high capacity tissue analytical services and provide a complete TissueAnalytics™ Software solution for implementation within its clients own laboratories. TissueInformatics lead investors include the Aurora Funds, Birchmere Ventures, the Future Fund, InforMax, Manulife Financial, Motorola, Smithfield Trust and Techno Venture Management (TVM).

"It is a great honor to have Dr. Peter Johnson as our new Co-Editor-in-Chief. Peter is world renowned for his expertise and contributions in the field of Tissue Engineering and we are confident in his abilities to take the Journal to the next level." Said Dr. Charles A. Vacanti MD, Co-Editor, Tissue Engineering and Vandam/Covinco Professor & Chair of Anaesthesia, Harvard Medical School. Dr. Vacanti will continue to serve as Co-Editor in Chief until January, 2004, when he will assume the role of Founding Editor.

Back to Portfolio News